Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit Beuselinck

Showing results (41-50 of 117) with videos related to

Pageof 12
Sort By:
Cancer Immunology, Immunotherapy : CII|November 12, 2010
A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findingsStéphane Oudard, Olivier Rixe, Benoit Beuselinck, et al.
Acta Oncologica (Stockholm, Sweden)|May 6, 2026
Incidence and impact of pseudoprogression and mixed responses in metastatic renal cell carcinoma patients treated with ipilimumab/nivolumab: a retrospective analysisAaron Caeyman, Giulia Mammone, Lisa Kinget, et al.
Plos One|September 11, 2020
MicroRNA expression profiles in molecular subtypes of clear-cell renal cell carcinoma are associated with clinical outcome and repression of specific mRNA targetsAnnelies Verbiest, Vincent Van Hoef, Cristina Rodriguez-Antona, et al.
Clinical Genitourinary Cancer|August 7, 2021
Molecular Subtypes and Gene Expression Signatures as Prognostic Features in Fully Resected Clear Cell Renal Cell Carcinoma: A Tailored Approach to Adjuvant TrialsEduard Roussel, Annelies Verbiest, Lisa Kinget, et al.
Acta Oncologica (Stockholm, Sweden)|November 3, 2017
Pro-angiogenic gene expression is associated with better outcome on sunitinib in metastatic clear-cell renal cell carcinomaBenoit Beuselinck, Annelies Verbiest, Gabrielle Couchy, et al.
Clinical Genitourinary Cancer|December 15, 2017
Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated With Outcome During Pazopanib Therapy in the Metastatic SettingAnnelies Verbiest, Gabrielle Couchy, Sylvie Job, et al.
European Urology|February 22, 2018
Molecular Subtypes of Clear-cell Renal Cell Carcinoma are Prognostic for Outcome After Complete MetastasectomyAnnelies Verbiest, Gabrielle Couchy, Sylvie Job, et al.
Cancers|April 3, 2021
MicroRNAs Possibly Involved in the Development of Bone Metastasis in Clear-Cell Renal Cell CarcinomaLisa Kinget, Eduard Roussel, Diether Lambrechts, et al.
Acta Oncologica (Stockholm, Sweden)|August 12, 2024
Baseline neutrophil-to-eosinophil-ratio and outcome in metastatic clear-cell renal cell carcinoma treated with nivolumab or ipilimumab/nivolumabYana Beulque, Lisa Kinget, Eduard Roussel, et al.
Acta Clinica Belgica|May 19, 2018
Prospective evaluation of hypogonadism in male metastatic renal cell carcinoma patients treated with targeted therapiesJulie Bastin, Emilie Werbrouck, Annelies Verbiest, et al.
Pageof 12

Showing results (41-50 of 117) with videos related to

Sort By:
Pageof 12
Cancer Immunology, Immunotherapy : CII|November 12, 2010
A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findingsStéphane Oudard, Olivier Rixe, Benoit Beuselinck, et al.
Acta Oncologica (Stockholm, Sweden)|May 6, 2026
Incidence and impact of pseudoprogression and mixed responses in metastatic renal cell carcinoma patients treated with ipilimumab/nivolumab: a retrospective analysisAaron Caeyman, Giulia Mammone, Lisa Kinget, et al.
Plos One|September 11, 2020
MicroRNA expression profiles in molecular subtypes of clear-cell renal cell carcinoma are associated with clinical outcome and repression of specific mRNA targetsAnnelies Verbiest, Vincent Van Hoef, Cristina Rodriguez-Antona, et al.
Clinical Genitourinary Cancer|August 7, 2021
Molecular Subtypes and Gene Expression Signatures as Prognostic Features in Fully Resected Clear Cell Renal Cell Carcinoma: A Tailored Approach to Adjuvant TrialsEduard Roussel, Annelies Verbiest, Lisa Kinget, et al.
Acta Oncologica (Stockholm, Sweden)|November 3, 2017
Pro-angiogenic gene expression is associated with better outcome on sunitinib in metastatic clear-cell renal cell carcinomaBenoit Beuselinck, Annelies Verbiest, Gabrielle Couchy, et al.
Clinical Genitourinary Cancer|December 15, 2017
Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated With Outcome During Pazopanib Therapy in the Metastatic SettingAnnelies Verbiest, Gabrielle Couchy, Sylvie Job, et al.
European Urology|February 22, 2018
Molecular Subtypes of Clear-cell Renal Cell Carcinoma are Prognostic for Outcome After Complete MetastasectomyAnnelies Verbiest, Gabrielle Couchy, Sylvie Job, et al.
Cancers|April 3, 2021
MicroRNAs Possibly Involved in the Development of Bone Metastasis in Clear-Cell Renal Cell CarcinomaLisa Kinget, Eduard Roussel, Diether Lambrechts, et al.
Acta Oncologica (Stockholm, Sweden)|August 12, 2024
Baseline neutrophil-to-eosinophil-ratio and outcome in metastatic clear-cell renal cell carcinoma treated with nivolumab or ipilimumab/nivolumabYana Beulque, Lisa Kinget, Eduard Roussel, et al.
Acta Clinica Belgica|May 19, 2018
Prospective evaluation of hypogonadism in male metastatic renal cell carcinoma patients treated with targeted therapiesJulie Bastin, Emilie Werbrouck, Annelies Verbiest, et al.
Pageof 12